Clearbridge Investments LLC raised its stake in Nutrien Ltd (NYSE:NTR) by 0.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 624,283 shares of the company’s stock after purchasing an additional 1,832 shares during the period. Clearbridge Investments LLC owned 0.11% of Nutrien worth $32,937,000 as of its most recent SEC filing.
Other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc boosted its stake in Nutrien by 0.4% in the 3rd quarter. Vanguard Group Inc now owns 16,810,545 shares of the company’s stock worth $969,968,000 after buying an additional 68,304 shares during the last quarter. Comerica Securities Inc. boosted its position in Nutrien by 11.6% during the 4th quarter. Comerica Securities Inc. now owns 5,971 shares of the company’s stock worth $283,000 after acquiring an additional 622 shares during the period. Cambridge Investment Research Advisors Inc. boosted its position in Nutrien by 5.8% during the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 19,740 shares of the company’s stock worth $928,000 after acquiring an additional 1,082 shares during the period. Stevens Capital Management LP lifted its holdings in shares of Nutrien by 12.2% in the fourth quarter. Stevens Capital Management LP now owns 12,097 shares of the company’s stock valued at $569,000 after buying an additional 1,311 shares during the period. Finally, Comerica Bank lifted its holdings in shares of Nutrien by 29.9% in the fourth quarter. Comerica Bank now owns 51,779 shares of the company’s stock valued at $2,672,000 after buying an additional 11,919 shares during the period. Institutional investors own 67.61% of the company’s stock.
A number of equities research analysts have recently issued reports on the company. Cowen raised Twitter from an “underperform” rating to a “market perform” rating in a research report on Tuesday, April 23rd. Zacks Investment Research raised Green Brick Partners from a “sell” rating to a “hold” rating in a research report on Wednesday, April 10th. Finally, Raymond James reaffirmed an “outperform” rating and issued a $36.00 target price on shares of Zymeworks in a research report on Thursday, May 30th. Five research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $61.50.
Nutrien (NYSE:NTR) last announced its quarterly earnings results on Thursday, May 9th. The company reported $0.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.24 by ($0.04). The firm had revenue of $3.69 billion for the quarter, compared to the consensus estimate of $3.71 billion. The business’s quarterly revenue was up .7% on a year-over-year basis. During the same period in the previous year, the business earned $0.16 EPS. As a group, equities research analysts forecast that Nutrien Ltd will post 2.94 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Thursday, July 18th. Shareholders of record on Friday, June 28th will be given a dividend of $0.43 per share. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $1.72 dividend on an annualized basis and a yield of 3.44%. Nutrien’s dividend payout ratio (DPR) is currently 63.94%.
Nutrien Company Profile
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.
Further Reading: Sell-Side Analysts
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.